191 related articles for article (PubMed ID: 17929269)
1. Downregulation of several fibulin genes in prostate cancer.
Wlazlinski A; Engers R; Hoffmann MJ; Hader C; Jung V; Müller M; Schulz WA
Prostate; 2007 Dec; 67(16):1770-80. PubMed ID: 17929269
[TBL] [Abstract][Full Text] [Related]
2. Plakophilin 1-deficient cells upregulate SPOCK1: implications for prostate cancer progression.
Yang C; Fischer-Kešo R; Schlechter T; Ströbel P; Marx A; Hofmann I
Tumour Biol; 2015 Dec; 36(12):9567-77. PubMed ID: 26138584
[TBL] [Abstract][Full Text] [Related]
3. Fibulin-1 is down-regulated through promoter hypermethylation and suppresses renal cell carcinoma progression.
Xiao W; Wang J; Li H; Guan W; Xia D; Yu G; Xiao H; Lang B; Ma X; Liu J; Zhang X; Ye Z; Xu H
J Urol; 2013 Jul; 190(1):291-301. PubMed ID: 23391467
[TBL] [Abstract][Full Text] [Related]
4. EFEMP1 as a novel DNA methylation marker for prostate cancer: array-based DNA methylation and expression profiling.
Kim YJ; Yoon HY; Kim SK; Kim YW; Kim EJ; Kim IY; Kim WJ
Clin Cancer Res; 2011 Jul; 17(13):4523-30. PubMed ID: 21571867
[TBL] [Abstract][Full Text] [Related]
5. Expression of extracellular matrix proteins fibulin-1 and fibulin-2 by human corneal fibroblasts.
Ducros E; Berthaut A; Mirshahi P; Lemarchand S; Soria J; Legeais JM; Mirshahi M
Curr Eye Res; 2007 Jun; 32(6):481-90. PubMed ID: 17612964
[TBL] [Abstract][Full Text] [Related]
6. Factor interaction analysis for chromosome 8 and DNA methylation alterations highlights innate immune response suppression and cytoskeletal changes in prostate cancer.
Schulz WA; Alexa A; Jung V; Hader C; Hoffmann MJ; Yamanaka M; Fritzsche S; Wlazlinski A; Müller M; Lengauer T; Engers R; Florl AR; Wullich B; Rahnenführer J
Mol Cancer; 2007 Feb; 6():14. PubMed ID: 17280610
[TBL] [Abstract][Full Text] [Related]
7. Changes in cortical cytoskeletal and extracellular matrix gene expression in prostate cancer are related to oncogenic ERG deregulation.
Schulz WA; Ingenwerth M; Djuidje CE; Hader C; Rahnenführer J; Engers R
BMC Cancer; 2010 Sep; 10():505. PubMed ID: 20860828
[TBL] [Abstract][Full Text] [Related]
8. Regulation and expression of human CYP7B1 in prostate: overexpression of CYP7B1 during progression of prostatic adenocarcinoma.
Olsson M; Gustafsson O; Skogastierna C; Tolf A; Rietz BD; Morfin R; Rane A; Ekström L
Prostate; 2007 Sep; 67(13):1439-46. PubMed ID: 17639508
[TBL] [Abstract][Full Text] [Related]
9. Hemicentin 2 and Fibulin 1 are required for epidermal-dermal junction formation and fin mesenchymal cell migration during zebrafish development.
Feitosa NM; Zhang J; Carney TJ; Metzger M; Korzh V; Bloch W; Hammerschmidt M
Dev Biol; 2012 Sep; 369(2):235-48. PubMed ID: 22771579
[TBL] [Abstract][Full Text] [Related]
10. Testis specific Y-like 5: gene expression, methylation and implications for drug sensitivity in prostate carcinoma.
Kumar SR; Bryan JN; Esebua M; Amos-Landgraf J; May TJ
BMC Cancer; 2017 Feb; 17(1):158. PubMed ID: 28235398
[TBL] [Abstract][Full Text] [Related]
11. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R
Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168
[TBL] [Abstract][Full Text] [Related]
12. Fibulin-5 is a tumour suppressor inhibiting cell migration and invasion in ovarian cancer.
Heo JH; Song JY; Jeong JY; Kim G; Kim TH; Kang H; Kwon AY; An HJ
J Clin Pathol; 2016 Feb; 69(2):109-16. PubMed ID: 26251522
[TBL] [Abstract][Full Text] [Related]
13. Methylation of Integrin α4 and E-Cadherin Genes in Human Prostate Cancer.
Mostafavi-Pour Z; Kianpour S; Dehghani M; Mokarram P; Torabinejad S; Monabati A
Pathol Oncol Res; 2015 Sep; 21(4):921-7. PubMed ID: 25743258
[TBL] [Abstract][Full Text] [Related]
14. CpG hypermethylation of the promoter region inactivates the estrogen receptor-beta gene in patients with prostate carcinoma.
Nojima D; Li LC; Dharia A; Perinchery G; Ribeiro-Filho L; Yen TS; Dahiya R
Cancer; 2001 Oct; 92(8):2076-83. PubMed ID: 11596023
[TBL] [Abstract][Full Text] [Related]
15. Fibulin-1 is epigenetically down-regulated and related with bladder cancer recurrence.
Xiao W; Wang J; Li H; Xia D; Yu G; Yao W; Yang Y; Xiao H; Lang B; Ma X; Guo X; Guan W; Xu H; Liu J; Zhang X; Ye Z
BMC Cancer; 2014 Sep; 14():677. PubMed ID: 25234557
[TBL] [Abstract][Full Text] [Related]
16. CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer.
Enokida H; Shiina H; Igawa M; Ogishima T; Kawakami T; Bassett WW; Anast JW; Li LC; Urakami S; Terashima M; Verma M; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
Cancer Res; 2004 Sep; 64(17):5956-62. PubMed ID: 15342374
[TBL] [Abstract][Full Text] [Related]
17. Frequent loss of cystatin E/M expression implicated in the progression of prostate cancer.
Pulukuri SM; Gorantla B; Knost JA; Rao JS
Oncogene; 2009 Aug; 28(31):2829-38. PubMed ID: 19503093
[TBL] [Abstract][Full Text] [Related]
18. Hypoexpression and epigenetic regulation of candidate tumor suppressor gene CADM-2 in human prostate cancer.
Chang G; Xu S; Dhir R; Chandran U; O'Keefe DS; Greenberg NM; Gingrich JR
Clin Cancer Res; 2010 Nov; 16(22):5390-401. PubMed ID: 21062931
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic inactivation of Betaig-h3 gene in human cancer cells.
Shao G; Berenguer J; Borczuk AC; Powell CA; Hei TK; Zhao Y
Cancer Res; 2006 May; 66(9):4566-73. PubMed ID: 16651406
[TBL] [Abstract][Full Text] [Related]
20. Fibulin-1 is downregulated through promoter hypermethylation in colorectal cancer: a CONSORT study.
Xu Z; Chen H; Liu D; Huo J
Medicine (Baltimore); 2015 Apr; 94(13):e663. PubMed ID: 25837757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
